Hyro AI has brought in $35 million in an extension of its series B round, recently securing an investment from Healthier Capital, led by former One Medical CEO Amir Rubin.
Macquarie Capital, Liberty Mutual and Black Opal Ventures also joined the round.
Hyro is a healthcare-specific no-code platform for AI-powered call center, web and mobile solutions. Hyro automates tasks like patient registration, IT help desk ticketing, frequently asked questions and prescription refills, which make up about two-thirds of all calls and messages received by contact center teams.
Hyro aims to meet healthcare consumers’ expectations for modernized, digital customer service experiences.
Founded in 2018, Hyro raised $4.5 million in its seed round and $10.5 million in its series A. In its series A, Spero Ventures, Mindset Ventures and Twilio joined “longtime investors” Hanaco Ventures, Spider Capital and Entrepreneurs Roundtable Accelerator, according to a press release by the company.
Hyro has rapidly expanded in the last year, doubling its U.S. revenue, staking claim at a slew of health systems including Intermountain Health, Inova Health System, Piedmont Healthcare, Prisma Health, Emory Healthcare and Texas Health Resources and forging partnerships with Salesforce and Cisco.
“Hyro is pushing the envelope in conversational AI by creating a unique knowledge graph from health system data which works in tandem with the latest advancements in LLMs,” Hyro co-founder Israel Krush said in an email to Fierce Healthcare. “This approach offers both ease and speed of deployment and maintenance, as well as a safer, controlled, and responsible implementation of the AI agents.”
Krush explained that Hyro is leading the conversational AI space because of its sole focus on healthcare and its founders’ healthcare domain expertise. Moreover, the solution is deeply integrated into workflows and electronic health records.
Customers have reported saving 35% on call center operations and seeing a fivefold return on investment, according to the company.
Rubin said Healthier Capital invested in Hyro because the company is improving access for healthcare consumers and improving response times for healthcare organizations.
“Using latest in safe AI approaches, Hyro is addressing the pressing needs of multiple key stakeholders in healthcare—from helping consumers more readily access healthcare services through voice and messaging conversational AI approaches seamlessly integrated into existing EHR and telephony systems—to helping healthcare organizations reduce turnaround times, abandonment rates, and staffing challenges,” Rubin said. “Accordingly, at Healthier Capital, we believe Hyro can fundamentally deliver better healthcare outcomes by improving service levels and reducing costs through modern and safe AI approaches.”
Rubin was chair and CEO of technology-enabled primary care company One Medical, which he took public in 2020 and sold to Amazon for $3.9 billion in 2023.
Hyro plans to use the series B funding to expand its call center solution to the pharmaceutical and payer industries and to develop more out-of-the-box skills for automating call and chat.